Kyverna Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.07

-0.44 (-5.86%)

As of Sep 23, 10:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +15.4% upside

Low Target $5.68

Average Target $8.16

High Target $10.96

Current Price $7.07

Current
$7.07

Target
$8.16

$5.68 $8.16 avg $10.96

Scenario Analysis

Bear Case

$5.68

-19.7%

Low target

Base Case

$8.16

+15.4%

Avg target

Bull Case

$10.96

+55.0%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$13.67

-48.3% from high

52-Week Low

$3.95

+79.0% from low

Target vs 52W High

$8.16

-40.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%